About Us
The American Society of Hematology (ASH) is the world's largest professional society dedicated to conquering blood diseases, serving over 18,000 clinicians and scientists across nearly 100 countries.
The 68th ASH Annual Meeting & Exposition will take place as a hybrid event from December 12-15, 2026, in person at the Ernest N. Morial Convention Center in New Orleans, Louisiana, and virtually online. It stands as the definitive global gathering for advancing classical and malignant hematologic science, covering breakthrough research in leukemia, lymphoma, sickle cell disease, and coagulation disorders.
About the American Society of Hematology (ASH):
Founded in 1958, ASH has shaped hematology into a distinct, high-impact medical discipline.
- Core Mission: To further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems.
- Global Network: Comprises a diverse membership of practicing hematologists, oncologists, clinical researchers, and medical trainees globally.
- Primary Publications: Directs highly cited medical literature, most notably the premier peer-reviewed journal, Blood.
What's New This Year in ASH:
The 2026 meeting reflects the immediate needs of cutting-edge clinical infrastructure and modern medical technologies:
- 2026 Preliminary Program Live Release: Rather than waiting until late autumn, the society has already published its 2026 Preliminary Program. Attendees can now map out specialized paths across the Education Program, Scientific Program, and key Marquee Sessions early.
- Heightened Focus on Healthcare AI & Informatics: Dedicated scientific tracks this year focus on using artificial intelligence in computational hematology, spanning automated diagnostics, machine learning for flow cytometry, and custom treatment planning algorithms.